In this issue:
- CRC screening: colonoscopy and faecal immunochemical testing
- Zanzalintinib + atezolizumab in refractory CRC
- Neoadjuvant CAPOX vs chemoradiation for LARC
- Paclitaxel + CRT, capecitabine and mitomycin C for SCAC
- Atezolizumab + mFOLFOX6 for dMMR colon cancer
- mFOLFOXIRI + panitumumab for RAS/BRAF wild-type mCRC
- TNT with short-course radiotherapy for LARC
- Circulating tumour DNA after resection of CRLM
- Trifluridine-tipiracil + bevacizumab in CRC
- Radiological staging in resectable pMMR colon cancer
Please login below to download this issue (PDF)